Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Peripheral Nerve Sheath Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07549022
What this trial is testing

Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor

Who this might be right for
Malignant Peripheral Nerve Sheath TumorsMPNST
Ankit Mangla, MD 17
Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Testing effectiveness (Phase 2)Study completedNCT03433183
What this trial is testing

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath TumorsNeurofibromatosis 1
Sarcoma Alliance for Research through Collaboration 21
Not applicableLooking for participantsNCT03141021
What this trial is testing

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors
Washington University School of Medicine 1,050
Testing effectiveness (Phase 2)Ended earlyNCT05011019
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis

Who this might be right for
Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 22
Early research (Phase 1)UnknownNCT05107037
What this trial is testing

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis

Who this might be right for
Type I Neurofibromatosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT00464620
What this trial is testing

Trial of Dasatinib in Advanced Sarcomas

Who this might be right for
RhabdomyosarcomaMalignant Peripheral Nerve Sheath TumorsChondrosarcoma+7 more
Sarcoma Alliance for Research through Collaboration 366
Testing effectiveness (Phase 2)Study completedNCT02584309
What this trial is testing

Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft TissueSoft Tissue SarcomaUndifferentiated Pleomorphic Sarcoma+8 more
Washington University School of Medicine 73
Early research (Phase 1)Study completedNCT01119599
What this trial is testing

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Acoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Ended earlyNCT05275478
What this trial is testing

Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Who this might be right for
Locally Advanced Solid Tumor
Tango Therapeutics, Inc. 110
Not applicableWithdrawnNCT01567787
What this trial is testing

Proton Radiation Therapy for Spinal Tumors

Who this might be right for
Nerve Sheath TumorsNeurofibroma
University of Florida
Large-scale testing (Phase 3)Study completedNCT00061984
What this trial is testing

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 455
Testing effectiveness (Phase 2)Looking for participantsNCT05985161
What this trial is testing

Selinexor in People With Wilms Tumors and Other Solid Tumors

Who this might be right for
Wilms TumorRhabdoid TumorMalignant Peripheral Nerve Sheath Tumors+4 more
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Looking for participantsNCT06735820
What this trial is testing

Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

Who this might be right for
Malignant Peripheral Nerve Sheath Tumor (MPNST)Neurofibromatosis 1 (NF1)Atypical Neurofibroma
AeRang Kim 45
Testing effectiveness (Phase 2)Looking for participantsNCT06277154
What this trial is testing

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma

Who this might be right for
LeiomyosarcomaLiposarcomaSynovial Sarcoma+8 more
HRYZ Biotech Co. 148
Testing effectiveness (Phase 2)Study completedNCT00474994
What this trial is testing

Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas

Who this might be right for
Adult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more
Memorial Sloan Kettering Cancer Center 53
Testing effectiveness (Phase 2)Study completedNCT00112463
What this trial is testing

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

Who this might be right for
Adult Alveolar Soft-part SarcomaAdult AngiosarcomaAdult Epithelioid Sarcoma+17 more
National Cancer Institute (NCI) 40
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Early research (Phase 1)Looking for participantsNCT04897321
What this trial is testing

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Who this might be right for
Pediatric Solid TumorOsteosarcomaRhabdomyosarcoma+13 more
St. Jude Children's Research Hospital 48
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Next Page